Results
| PMID | 25298284 |
| Gene Name | RASSF2 |
| Condition | Endometriosis (ovarian) |
| Association |
Associated |
| Population size | 30 |
| Population details | 50 (30 EMS-associated ovarian carcinoma (18 Ovarian endometrioid cancer, 12 ovarian clear cell cancer), 20 normal endometrial specimens) |
| Sex | Female |
| Associated genes | RASSF2, RUNX3, GSTZ1, CYP2A, GBGT1, NDUFS1, SPOCK2, ADAM22, and TRIM36 |
| Other associated phenotypes |
Endometriosis-associated ovarian carcinoma, Ovarian endometrioid cancer (OEC) and ovarian clear cell cancer (OCCC) |
|
J Ovarian Res. 2014 Jul 10;7:73. doi: 10.1186/1757-2215-7-73. Ren, Fang| Wang, Dan-Bo| Li, Tong| Chen, Ying-Han| Li, Yan BACKGROUND: Key roles for epigenetic mechanisms in tumorigenesis are well accepted, while the relationship between gene methylation and malignant transformation of ovarian endometriosis (EMS) was seldom reported. In this study, we aimed to screen for aberrantly methylated genes associated with the malignant transformation of ovarian EMS and to preliminarily verify the reliability of screened results by detecting the methylation status and protein expression of the candidate gene in a larger scale of formaldehyde-fixed and paraffin-embedded (FFPE) samples. METHODS: Methylated CpG island amplification coupled with representational difference analysis (MCA-RDA) was performed on 3 couples of endometriosis-associated ovarian carcinoma (EAOC) fresh samples to identify differentially methylated candidate genes related to malignant transformation of ovarian EMS; Methylation-specific PCR (MSP) and immunohistochemistry were performed in 30 EAOC samples to detected the methylation status and protein expression of RASSF2 gene to verify the reliability of MCA-RDA results. RESULTS: Nine differentially methylated genes were obtained by MCA-RDA as candidate genes for malignant transformation of EMS; Methylation frequency of RASSF2 in the neoplastic tissues of EAOC group was higher than that in the ectopic endometria (p < 0.05). While protein expression of RASSF2 in the neoplastic tissues was lower than that in the ectopic endometria of the EAOC group (p < 0.05) Absence of protein expression of RASSF2 was significantly correlated with the promoter methylation of the gene (p < 0.05). CONCLUSIONS: RASSF2, RUNX3, GSTZ1, CYP2A, GBGT1, NDUFS1, SPOCK2, ADAM22, and TRIM36 were candidate genes for malignant transformation of ovarian EMS and epigenetic inactivation of RASSF2 by promoter hypermethylation is an early event in malignant transformation of ovarian EMS. The screen results were reliable and worthy of further study. Mesh Terms: Adult| Cell Transformation, Neoplastic/*genetics| CpG Islands| *DNA Methylation| Endometriosis/*genetics/metabolism/*pathology| Epigenesis, Genetic| Female| *Gene Expression Regulation, Neoplastic| Gene Silencing| Humans| Middle Aged| Neoplasms |
|